Abstract 9532: Anaemic Patients With Chronic Heart Failure are Common in Clinical Practice, Insufficiently Treated and With an Impaired Prognosis Independent of Confounding Factors

• Published in: Circulation (New York, N.Y.) N.Y.), 2012-11, Vol.126 (suppl_21)
• Main Authors: Wienbergen, Harm, Osteresch, Rico, Hochadel, Matthias, Boehm, Michael, Pauschinger, Matthias, Strasser, Ruth H, von Scheidt, Wolfgang, Senges, Jochen, Hambrecht, Rainer
• Format: Article
• Language: English
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/circ.126.suppl_21.A9532

Abstract only Introduction: There is an increasing interest in the role of anaemia in patients with heart failure (HF). We analyzed data of the EVITA-HF registry with respect to prevalence, therapy and prognosis of patients with chronic HF and hemoglobin < 12 g/dl in the actual clinical practice. Methods: The EVITA-HF registry is a multicenter registry of consecutive patients with chronic HF and left ventricular ejection fraction < 40%. Data are collected in 17 centers in Germany, Austria and Switzerland. Results: 3082 HF-patients were included in the EVITA-HF registry in the time period 01/2009 to 03/2012. In 734 patients (23.8%) hemoglobin levels were < 12 g/dl. Anaemic patients were older (71 + 12 years vs. 65 + 13 years, p < 0.01) and more often female (33.2% vs. 20.6%, p < 0.01) than patients without anaemia and had a higher rate of comorbidities as renal failure and malignant comorbidities. Patients with anaemia received less often adequate medical HF-therapy (especially ACE inhibitors, aldosterone antagonists), had a lower rate of oral anticoagulatives in spite of a high rate of atrial fibrillation and had less often ICD/CRT implanted (32.1% vs. 40.3%, p